Log in to save to my catalogue

Enhanced endothelin-1 degradation by intravenous morphine in patients with congestive heart failure:...

Enhanced endothelin-1 degradation by intravenous morphine in patients with congestive heart failure:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1767539

Enhanced endothelin-1 degradation by intravenous morphine in patients with congestive heart failure: role of neutral endopeptidase 24.11

About this item

Full title

Enhanced endothelin-1 degradation by intravenous morphine in patients with congestive heart failure: role of neutral endopeptidase 24.11

Author / Creator

Publisher

England: BMJ Publishing Group Ltd and British Cardiovascular Society

Journal title

British heart journal, 2003-02, Vol.89 (2), p.211-212

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Cardiovascular Society

More information

Scope and Contents

Contents

DISCUSSION In this report we have shown that morphine activated NEP and thereafter reduced plasma ET-1 concentration, with a concomitant increase of C-terminal degradation peptides in patients with dilated cardiomyopathy and heart failure. Because of the effects of ET-1 on haemodynamic derangement in patients with CHF, some investigators promoted s...

Alternative Titles

Full title

Enhanced endothelin-1 degradation by intravenous morphine in patients with congestive heart failure: role of neutral endopeptidase 24.11

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1767539

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1767539

Other Identifiers

ISSN

1355-6037,0007-0769

E-ISSN

1468-201X

DOI

10.1136/heart.89.2.211

How to access this item